Literature DB >> 32527866

Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort.

Luisa Costa1, Marco Tasso1, Nadia Scotti1, Erika Mostacciuolo1, Nicolò Girolimetto1, Francesca Foglia1, Antonio Del Puente1, Raffaele Scarpa2, Francesco Caso1.   

Abstract

Entities:  

Keywords:  antirheumatic agents; arthritis, psoriatic; biological therapy; tumour necrosis factor inhibitors

Mesh：

Substances：

Year:  2020        PMID： 32527866     DOI： 10.1136/annrheumdis-2020-217806

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  6 in total

1.  Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands.

Authors:  Wouter H Bos; Astrid van Tubergen; Harald E Vonkeman
Journal:  Rheumatol Int       Date:  2021-01-15       Impact factor: 2.631

2.  Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines.

Authors:  Nelly Ziade; Ihsane Hmamouchi; Lina El Kibbi; Melissa Daou; Nizar Abdulateef; Fatemah Abutiban; Bassel Elzorkany; Chafia Dahou-Makhloufi; Wafa Hamdi; Samar Al Emadi; Hussein Halabi; Khalid A Alnaqbi; Sima Abu Al Saoud; Soad Hashad; Radouane Niamane; Manal El Rakawi; Layla Kazkaz; Sahar Saad; Mervat Eissa; Ilanca Fraser; Basel Masri
Journal:  Rheumatol Int       Date:  2022-01-06       Impact factor: 3.580

3.  Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series.

Authors:  Xenofon Baraliakos; Styliani Tsiami; Sooraj Vijayan; Haewon Jung; Nick Barkham
Journal:  Clin Case Rep       Date:  2022-01-20

4.  Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature.

Authors:  Nicola Luigi Bragazzi; Charlie Bridgewood; Abdulla Watad; Giovanni Damiani; Jude Dzevela Kong; Dennis McGonagle
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 5.  COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges.

Authors:  Saikat Dewanjee; Ramesh Kandimalla; Rajkumar Singh Kalra; Chandrasekhar Valupadas; Jayalakshmi Vallamkondu; Viswakalyan Kolli; Sarbani Dey Ray; Arubala P Reddy; P Hemachandra Reddy
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

6.  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

Authors:  Joel M Gelfand; April W Armstrong; Stacie Bell; George L Anesi; Andrew Blauvelt; Cassandra Calabrese; Erica D Dommasch; Steve R Feldman; Dafna Gladman; Leon Kircik; Mark Lebwohl; Vincent Lo Re; George Martin; Joseph F Merola; Jose U Scher; Sergio Schwartzman; James R Treat; Abby S Van Voorhees; Christoph T Ellebrecht; Justine Fenner; Anthony Ocon; Maha N Syed; Erica J Weinstein; Jessica Smith; George Gondo; Sue Heydon; Samantha Koons; Christopher T Ritchlin
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 15.487
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.